Phase I trial of VTX 1463 in healthy volunteers.

Trial Profile

Phase I trial of VTX 1463 in healthy volunteers.

Phase of Trial: Phase I

Latest Information Update: 13 Jan 2010

At a glance

  • Drugs VTX 1463 (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 13 Jan 2010 Status changed from recruiting to completed as reported in a VentiRx Pharmaceuticals media release.
    • 23 Apr 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top